Mind Control Game “CogoLand” Proven Effective in Reducing ADHD Symptoms
Neeuro to soon make available “CogoLand” for clinicians to prescribe to children with ADHD
Singapore January 25, 2019 — NEEURO PTE. LTD., a leader in digital brain health and education technology, announced in its latest white paper a recent neuroimaging study that proves the effectiveness of a non-invasive therapeutic approach in treating children with ADHD symptoms. The approach uses a Brain-Computer Interface (BCI) based game called “CogoLand”. The brain imaging study suggested that BCI-based attention training facilitates behavioral improvement in children with ADHD by reorganizing brain functional network that is responsible for attention.
Clinical applications using “CogoLand” have proven the effectiveness of the technology in reducing symptoms of ADHD, avoiding the downsides of current therapies as it is non-invasive, conveniently digital, and easily accessible to those without affordable and accessible medical care.
In over 10 years of research and development to seek digital convenient brain training solutions, Neeuro’s latest announcement further strengthens available evidence in the use of BCI technology to improve attention as one of the key foundations for good cognitive function. In its pilot study entitled, Effectiveness of a brain-computer interface based programme for the treatment of ADHD: a pilot study, children with ADHD showed greater improvement in attention scores on the ADHD Rating Scale (ADHD RS) after going through the BCI-based brain training game.
In a further trial in 2012 using “CogoLand” entitled, A Brain-Computer Interface Based Attention Training Program for Treating Attention Deficit Hyperactivity Disorder, results indicated that BCI-based attention training can be a potential new treatment for ADHD. In the same trial, parents also reported significant improvements in their children’s behaviors, particularly in their inattentive symptoms, as well as in their hyperactive-impulsive symptoms.
In its much-anticipated follow-up study, with one of the largest samples of children with ADHD ever examined, researchers found that children in the intervention group (those who went through the BCI-based training) showed reorganized brain network activity – increased closeness in the prefrontal region of the brain that is associated with attention. These findings are now available in the peer-reviewed journal Translational Psychiatry published by Nature. The study is part of a larger randomized controlled study consisting of 172 children with ADHD.
Sign up and get our monthly newsletters!
The research has been backed and supported by the National Medical Research Council, Singapore and Duke-NUS Medical School Signature Research Program funded by the Ministry of Health in Singapore. Neeuro’s white paper, entitled “A Brain-Computer Interface Brain Training Game “CogoLand” for Children with Attention Deficit Hyperactivity Disorder” can now be viewed and downloaded online. The study suggests that more focused brain area is activated after BCI intervention as compared with very widespread activation of multiple brain areas in children from the non-intervention group.
Being a worldwide leader in making brain training technology available for the masses and winning multiple awards, Neeuro has multiple studies and clinical trials done that has shown evidence and efficacies with BCI-based brain training across the various spectrum of mental health, from children to seniors. The BCI-based brain training game “CogoLand” used in the clinical studies will be soon made available for clinicians to prescribe to children with ADHD. Dr. Alvin Chan, the Chief Executive Officer at NEEURO PTE. LTD. shares his excitement about the big announcement:
“This is a testament to how BCI-based brain training can positively impact the lives of individuals especially in this case with children diagnosed with ADHD.”
Today, Neeuro has adapted the successes from “CogoLand”, integrating the BCI-based technology to its brain training solutions, “Memorie” and “Smarty Knights”, making it available to all children seeking to improve their attention and other cognitive functions. Neeuro’s white paper on “CogoLand” for children with ADHD can be downloaded here.
About ADHD: There has been a growing number of Attention Deficit Hyperactivity Disorder (ADHD) cases in people aged 5 to 44 years worldwide. ADHD is one of the most commonly diagnosed neuropsychiatric or cognitive disorders of childhood that afflicts approximately 2-7% of children worldwide. Common symptoms represented by 38-57% of ADHD children are inattention and lack of focus. Nobody has completely understood the base of ADHD and many medical practitioners claimed that this is a genetic disorder. Hence, it is difficult to get cured completely and the most common treatment is pharmacotherapy. Recently, electroencephalography (EEG)-based neurofeedback has been proven as an alternative treatment for ADHD.
About Neeuro Pte. Ltd.: Neeuro is a global company which specialises in the utilisation of Brain Computer Interface technology to maximise the potential of users’ neurological agility and fitness. Neeuro’s portfolio and array of offerings are backed by clinically validated research with A*STAR, widely known as being at the forefront of Singapore’s research endeavours, to empower digital therapeutics and brain fitness solutions.
Its core technology, NeeuroOS, is a platform ecosystem that empowers health care professionals, researchers and third party developers with an Artificial Intelligence (AI) driven platform which analyses the brain signals of users; measuring mental states, such as attention, relaxation and fatigue, to name a few. This is coupled with Neeuro’s other offerings enable potential avenues to address problems associated with ADHD children, patients with stroke, cognitive rehabilitation and many other neurological issues. (https://www.neeuro.com).